Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

25 Results
Author: personID (integer) : 755892
Image document

High Fragmentation Characterizes Tumour-Derived Circulating DNA

Florent Mouliere , Bruno Robert , Erika Arnau Peyrotte , Maguy del Rio , Marc Ychou , et al.
PLoS ONE, 2011, 6 (9), pp.e23418. ⟨10.1371/journal.pone.0023418⟩
Journal articles hal-02362667v1
Image document

TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT.

Najoua Lalaoui , Aymeric Morlé , Delphine Mérino , Guillaume Jacquemin , Elisabetta Iessi , et al.
PLoS ONE, 2011, 6 (5), pp.e19679. ⟨10.1371/journal.pone.0019679⟩
Journal articles inserm-00590415v1
Image document

Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells

Nadia Vié , Virginie Copois , Caroline Mollevi , Vincent Denis , Nicole Bec , et al.
Molecular Cancer, 2008, 7 (1), pp.14. ⟨10.1186/1476-4598-7-14⟩
Journal articles inserm-00230202v1
Image document

Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.

Yassamine Lazrek , Olivier Dubreuil , Véronique Garambois , Nadège Gaborit , Christel Larbouret , et al.
Neoplasia, 2013, 15 (3), pp.335-47. ⟨10.1593/neo.121960⟩
Journal articles inserm-00815985v1
Image document

In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption.

Christel Larbouret , Nadège Gaborit , Thierry Chardès , Mickaël Coelho , Emmanuelle Campigna , et al.
Neoplasia, 2012, 14 (2), pp.121-30. ⟨10.1593/neo.111602⟩
Journal articles inserm-00682017v1
Image document

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

Gaëlle Thomas , Thierry Chardès , Nadège Gaborit , Caroline Mollevi , Wilhem Leconet , et al.
Oncotarget, 2014, 5 (16), pp.7138-7148. ⟨10.18632/oncotarget.2231⟩
Journal articles hal-02387994v2
Image document

Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells

Maëva Chauvin , Véronique Garambois , Pierre-Emmanuel Colombo , Myriam Chentouf , Laurent Gros , et al.
Scientific Reports, 2021, 11, pp.2231. ⟨10.1038/s41598-021-81819-y⟩
Journal articles hal-03131997v1
Image document

Energy transfer and trapping in $Synechococcus$ WH 7803

Alonso M. Acuña , Claire Lemaire , Rienk Van Grondelle , Bruno Robert , Ivo H. M. Van Stokkum
Photosynthesis Research, 2018, 135 (1-3), pp.115-124. ⟨10.1007/s11120-017-0451-2⟩
Journal articles hal-02175117v1
Image document

Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer

Charline Ogier , Pierre-Emmanuel Colombo , Corinne Bousquet , Lucile Canterel-Thouennon , Pierre Sicard , et al.
Cancer Letters, 2018, 432, pp.227-236. ⟨10.1016/j.canlet.2018.06.023⟩
Journal articles hal-02350723v1
Image document

Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.

Christel Larbouret , Bruno Robert , Christine Linard , Isabelle Teulon , Sophie Gourgou , et al.
International Journal of Radiation Oncology, Biology, Physics, 2007, 69 (4), pp.1231-7. ⟨10.1016/j.ijrobp.2007.07.2372⟩
Journal articles inserm-00225077v1
Image document

[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment]

Christel Larbouret , Bruno Robert , Isabelle Teulon , Eric Assénat , David Azria , et al.
Bulletin du Cancer, 2007, 94 (10), pp.860-2
Journal articles inserm-00192243v1
Image document

[Anti-EGFR and anti-HER2 monoclonal antibodies against pancreatic carcinomas]

Christel Larbouret , Bruno Robert , Isabelle Teulon , David Azria , André Pèlegrin
Médecine/Sciences, 2007, 23 (10), pp.800-3
Journal articles inserm-00192336v1
Image document

Singlet fission in naturally-organized carotenoid molecules

Annamaria Quaranta , Anja Krieger-Liszkay , Andrew Pascal , François Perreau , Bruno Robert , et al.
Physical Chemistry Chemical Physics, 2021, 23 (8), pp.4768-4776. ⟨10.1039/D0CP04493H⟩
Journal articles hal-03282317v1
Image document

Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump.

Thibault Mazard , Annick Causse , Joelle Simony , Wilhem Leconet , Nadia Vezzio-Vie , et al.
Molecular Cancer Therapeutics, 2013, 12 (10), pp.2121-34. ⟨10.1158/1535-7163.MCT-12-0966⟩
Journal articles inserm-00861055v1
Image document

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

Yahya Ashraf , Hanane Mansouri , Valérie Laurent-Matha , Lindsay B Alcaraz , Pascal Roger , et al.
Journal for Immunotherapy of Cancer, 2019, 7 (1), pp.29-46. ⟨10.1186/s40425-019-0498-z⟩
Journal articles hal-02335397v1
Image document

Carotenoid composition and conformation in retinal oil droplets of the domestic chicken

Ana-Andreea Arteni , Amy M. Lafountain , Maxime T. A. Alexandre , Mathias Fradot , Maria M. Mendes-Pinto , et al.
PLoS ONE, 2019, 14 (5), pp.e0217418. ⟨10.1371/journal.pone.0217418⟩
Journal articles hal-02169471v1
Image document

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer

Maya Jeitany , Cédric Leroy , Priscillia Tosti , Marie Lafitte , Jordy Le Guet , et al.
EMBO Molecular Medicine, 2018, 10 (4), pp.e7918. ⟨10.15252/emmm.201707918⟩
Journal articles hal-01872978v1
Image document

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors

Diego Sanchez , Nerea Allende-Vega , Stefania Orecchioni , Giovanna Talarico , Amélie Cornillon , et al.
Theranostics, 2018, 8 (14), pp.3856-3869. ⟨10.7150/thno.25149⟩
Journal articles inserm-02351977v1

Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival

Maëva Chauvin , Véronique Garambois , Sylvie Choblet , Pierre-Emmanuel Colombo , Myriam Chentouf , et al.
International Journal of Oncology, 2021, 59 (1), ⟨10.3892/ijo.2021.5223⟩
Journal articles hal-03229123v1
Image document

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

Alain Thierry , Florent Mouliere , Celine Gongora , Jérémy Ollier , Bruno Robert , et al.
Nucleic Acids Research, 2010, 38 (18), pp.6159-6175. ⟨10.1093/nar/gkq421⟩
Journal articles hal-02362686v1
Image document

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.

Christelle Larbouret , Bruno Robert , Caroline Bascoul-Mollevi , Frédérique Penault-Llorca , Alexandre Ho-Pun-Cheung , et al.
Annals of Oncology, 2010, 21 (1), pp.98-103. ⟨10.1093/annonc/mdp496⟩
Journal articles inserm-00431431v1
Image document

Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat.

Nathalie Bouquier , Sylvie Fromont , Jean-Christophe Zeeh , Camille Auziol , Pauline Larrousse , et al.
Chemistry and Biology, 2009, 16 (4), pp.391-400. ⟨10.1016/j.chembiol.2009.02.006⟩
Journal articles hal-00392842v1
Image document

Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.

Cédric Leroy , Camille Fialin , Audrey Sirvent , Valérie Simon , Serge Urbach , et al.
Cancer Research, 2009, 69 (6), pp.2279-86. ⟨10.1158/0008-5472.CAN-08-2354⟩
Journal articles hal-00367875v1
Image document

In vivo Therapeutic Synergism of Anti-Epidermal Growth Factor Receptor and Anti-HER2 Monoclonal Antibodies against Pancreatic Carcinomas.

Christel Larbouret , Bruno Robert , Isabelle Navarro-Teulon , Simon Thèzenas , Maha-Zohra Ladjemi , et al.
Clinical Cancer Research, 2007, 13 (11), pp.3356-62. ⟨10.1158/1078-0432.CCR-06-2302⟩
Journal articles inserm-00153693v1
Image document

[Bispecific antibodies: what future?]

André Pèlegrin , Bruno Robert
Médecine/Sciences, 2009, 25 (12), pp.1155-8. ⟨10.1051/medsci/200925121155⟩
Journal articles inserm-00446432v1